$ALOT
AstroNova, Inc.

2023 Q2 Form 10-Q Financial Statement

#000119312523163282 Filed on June 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2
Revenue $35.42M $31.01M
YoY Change 14.22% 6.64%
Cost Of Revenue $23.03M $20.28M
YoY Change 13.57% 11.5%
Gross Profit $12.39M $10.73M
YoY Change 15.43% -1.46%
Gross Profit Margin 34.97% 34.6%
Selling, General & Admin $9.136M $8.443M
YoY Change 8.21% 0.08%
% of Gross Profit 73.77% 78.69%
Research & Development $1.788M $1.522M
YoY Change 17.48% -11.36%
% of Gross Profit 14.44% 14.19%
Depreciation & Amortization $1.055M $912.0K
YoY Change 15.68% -36.0%
% of Gross Profit 8.52% 8.5%
Operating Expenses $10.92M $9.965M
YoY Change 9.62% -1.85%
Operating Profit $1.461M $764.0K
YoY Change 91.23% 3.95%
Interest Expense $615.0K -$100.0K
YoY Change -715.0%
% of Operating Profit 42.09% -13.09%
Other Income/Expense, Net -$434.0K -$179.0K
YoY Change 142.46% -51.49%
Pretax Income $1.027M $485.0K
YoY Change 111.75% 32.51%
Income Tax $179.0K $60.00K
% Of Pretax Income 17.43% 12.37%
Net Earnings $848.0K $425.0K
YoY Change 99.53% -28.33%
Net Earnings / Revenue 2.39% 1.37%
Basic Earnings Per Share $0.12 $0.06
Diluted Earnings Per Share $0.11 $57.46K
COMMON SHARES
Basic Shares Outstanding 7.401M 7.263M
Diluted Shares Outstanding 7.450M 7.361M

Balance Sheet

Concept 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.413M $5.754M
YoY Change -5.93% -49.59%
Cash & Equivalents $5.413M $5.754M
Short-Term Investments
Other Short-Term Assets $2.578M $4.233M
YoY Change -39.1% 111.86%
Inventory $53.13M $36.86M
Prepaid Expenses
Receivables $19.29M $18.54M
Other Receivables $0.00 $0.00
Total Short-Term Assets $80.50M $65.39M
YoY Change 23.11% 12.34%
LONG-TERM ASSETS
Property, Plant & Equipment $13.92M $11.95M
YoY Change 16.43% -10.96%
Goodwill $14.76M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.328M $6.076M
YoY Change 20.61% -4.48%
Total Long-Term Assets $58.69M $49.79M
YoY Change 17.89% -7.54%
TOTAL ASSETS
Total Short-Term Assets $80.50M $65.39M
Total Long-Term Assets $58.69M $49.79M
Total Assets $139.2M $115.2M
YoY Change 20.86% 2.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.000M $6.952M
YoY Change 15.07% 23.28%
Accrued Expenses $3.484M $6.278M
YoY Change -44.5% -1.89%
Deferred Revenue $443.0K
YoY Change
Short-Term Debt $15.90M $3.000M
YoY Change 430.0%
Long-Term Debt Due $2.100M $1.000M
YoY Change 110.0% 23.0%
Total Short-Term Liabilities $37.43M $21.40M
YoY Change 74.91% 38.59%
LONG-TERM LIABILITIES
Long-Term Debt $11.68M $7.910M
YoY Change 47.64% -40.55%
Other Long-Term Liabilities $4.441M $5.030M
YoY Change -11.71% -31.79%
Total Long-Term Liabilities $11.68M $12.94M
YoY Change -9.75% -37.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $37.43M $21.40M
Total Long-Term Liabilities $11.68M $12.94M
Total Liabilities $53.72M $34.48M
YoY Change 55.81% -5.59%
SHAREHOLDERS EQUITY
Retained Earnings $60.02M
YoY Change
Common Stock $62.06M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $34.59M
YoY Change
Treasury Stock Shares $3.368M
Shareholders Equity $85.47M $80.70M
YoY Change
Total Liabilities & Shareholders Equity $139.2M $115.2M
YoY Change 20.86% 2.78%

Cashflow Statement

Concept 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $848.0K $425.0K
YoY Change 99.53% -28.33%
Depreciation, Depletion And Amortization $1.055M $912.0K
YoY Change 15.68% -36.0%
Cash From Operating Activities $2.642M -$1.614M
YoY Change -263.69% -141.29%
INVESTING ACTIVITIES
Capital Expenditures $48.00K -$50.00K
YoY Change -196.0% -90.81%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$48.00K -$50.00K
YoY Change -4.0% -90.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $88.00K
YoY Change 69.23%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.182M 2.089M
YoY Change -156.58% -161.1%
NET CHANGE
Cash From Operating Activities 2.642M -1.614M
Cash From Investing Activities -48.00K -50.00K
Cash From Financing Activities -1.182M 2.089M
Net Change In Cash 1.467M 425.0K
YoY Change 245.18% -887.04%
FREE CASH FLOW
Cash From Operating Activities $2.642M -$1.614M
Capital Expenditures $48.00K -$50.00K
Free Cash Flow $2.594M -$1.564M
YoY Change -265.86% -135.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000008146
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-04-29
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
0-13200
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
AstroNova, Inc.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
RI
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
05-0318215
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
600 East Greenwich Avenue
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
West Warwick
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
RI
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02893
CY2023Q2 dei City Area Code
CityAreaCode
401
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
828-4000
CY2023Q2 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q2 dei Trading Symbol
TradingSymbol
ALOT
CY2023Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7417715
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5413000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3946000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19285000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21598000
CY2023Q2 us-gaap Inventory Net
InventoryNet
53126000
CY2023Q1 us-gaap Inventory Net
InventoryNet
51324000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2678000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2894000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
80502000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
79762000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13918000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14288000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20630000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21232000
CY2023Q2 us-gaap Goodwill
Goodwill
14760000
CY2023Q1 us-gaap Goodwill
Goodwill
14658000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6907000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6907000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
858000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
794000
CY2023Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1621000
CY2023Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1566000
CY2023Q2 us-gaap Assets
Assets
139196000
CY2023Q1 us-gaap Assets
Assets
139207000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
8000000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
8479000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3267000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2750000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3484000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3308000
CY2023Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
15900000
CY2023Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
15900000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2100000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2100000
CY2023Q2 alot Royalty Obligation Current
RoyaltyObligationCurrent
1600000
CY2023Q1 alot Royalty Obligation Current
RoyaltyObligationCurrent
1725000
CY2023Q2 alot Accrued Royalties Current Excess Royalty Payment Due
AccruedRoyaltiesCurrentExcessRoyaltyPaymentDue
379000
CY2023Q1 alot Accrued Royalties Current Excess Royalty Payment Due
AccruedRoyaltiesCurrentExcessRoyaltyPaymentDue
562000
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
730000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
786000
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1971000
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1888000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
37431000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
37498000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11678000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12040000
CY2023Q2 alot Royalty Obligation Non Current
RoyaltyObligationNonCurrent
3102000
CY2023Q1 alot Royalty Obligation Non Current
RoyaltyObligationNonCurrent
3415000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
581000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
555000
CY2023Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
491000
CY2023Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
491000
CY2023Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
267000
CY2023Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
674000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
172000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
167000
CY2023Q2 us-gaap Liabilities
Liabilities
53722000
CY2023Q1 us-gaap Liabilities
Liabilities
54840000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10780934
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10676851
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
538000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
534000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61526000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61131000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
60023000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
59175000
CY2023Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
3368219
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3342032
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
34585000
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
34235000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2028000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2238000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
85474000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
84367000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
139196000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
139207000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35419000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31010000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
23034000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
20281000
CY2023Q2 us-gaap Gross Profit
GrossProfit
12385000
CY2022Q2 us-gaap Gross Profit
GrossProfit
10729000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6010000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5883000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1788000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1522000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3126000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2560000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
10924000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
9965000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1461000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
764000
CY2023Q2 us-gaap Interest Expense
InterestExpense
615000
CY2022Q2 us-gaap Interest Expense
InterestExpense
175000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
186000
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-135000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-434000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-279000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1027000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
485000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
179000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
848000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
425000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7370000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7263000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7450000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7361000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
848000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
425000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
210000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-933000
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
0
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-16000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
210000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-917000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1058000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-492000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
81012000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
337000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
88000
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-249000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
425000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-917000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
80696000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
84367000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
356000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
43000
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-350000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
848000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
210000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
85474000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
848000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
425000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1055000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
912000
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
6000
CY2022Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
7000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
356000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
337000
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2324000
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1489000
CY2023Q2 alot Other Employee Retention Credit Receivable
OtherEmployeeRetentionCreditReceivable
0
CY2022Q2 alot Other Employee Retention Credit Receivable
OtherEmployeeRetentionCreditReceivable
-3135000
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1756000
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2650000
CY2023Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
38000
CY2022Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
502000
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8000
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2843000
CY2023Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
237000
CY2022Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-50000
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2642000
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1614000
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48000
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50000
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48000
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50000
CY2023Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
18000
CY2022Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
69000
CY2023Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
25000
CY2022Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
19000
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
350000
CY2022Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
249000
CY2023Q2 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0
CY2022Q2 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
3000000
CY2023Q2 alot Payments Of Minimum Guarantee Royalty Obligation
PaymentsOfMinimumGuaranteeRoyaltyObligation
500000
CY2022Q2 alot Payments Of Minimum Guarantee Royalty Obligation
PaymentsOfMinimumGuaranteeRoyaltyObligation
500000
CY2023Q2 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
375000
CY2022Q2 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
250000
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1182000
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2089000
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55000
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1467000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
478000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3946000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5276000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5413000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5754000
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
538000
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
53000
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
235000
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-440000
CY2023Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q3 us-gaap Area Of Land
AreaOfLand
34460
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
443000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
412000
CY2023Q1 alot Contract With Customer Liability Revenue Recognized Including Additions
ContractWithCustomerLiabilityRevenueRecognizedIncludingAdditions
143000
CY2023Q2 alot Capitalized Contract Costs Amortization Period Remaining
CapitalizedContractCostsAmortizationPeriodRemaining
P18Y
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1400000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
91000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
3393000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
5715000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
4200000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
3480000
CY2022Q3 alot Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill
2730000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
2484000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
17125000
CY2022Q3 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
3480000
CY2023Q1 alot Royalty Guarantee Commitement Amount Due Current And Non Current Discounted Value
RoyaltyGuaranteeCommitementAmountDueCurrentAndNonCurrentDiscountedValue
500000
CY2023 us-gaap Royalty Expense
RoyaltyExpense
100000
CY2023Q2 alot Royalty Guarantee Commitement Amount Due Current And Non Current Discounted Value
RoyaltyGuaranteeCommitementAmountDueCurrentAndNonCurrentDiscountedValue
500000
CY2023Q2 us-gaap Royalty Expense
RoyaltyExpense
100000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35419000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31010000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35419000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31010000
CY2023Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
19000
CY2022Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
16000
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1300000
CY2023Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
100000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7369930
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7262797
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
80122
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
97713
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7450052
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7360510
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
656554
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
310588
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
40447000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19950000
CY2023Q2 alot Finite Lived Intangible Assets Foreign Currency Translation Adjustment
FiniteLivedIntangibleAssetsForeignCurrencyTranslationAdjustment
133000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20630000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
40447000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19336000
CY2023Q1 alot Finite Lived Intangible Assets Foreign Currency Translation Adjustment
FiniteLivedIntangibleAssetsForeignCurrencyTranslationAdjustment
121000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21232000
CY2023Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2022Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
14250000
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
97000
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
110000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1786000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1723000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1723000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1723000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1281000
CY2023Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
40624000
CY2023Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
38387000
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1485000
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
1146000
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
22221000
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
23221000
CY2023Q2 us-gaap Inventory Gross
InventoryGross
64330000
CY2023Q1 us-gaap Inventory Gross
InventoryGross
62754000
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
11204000
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
11430000
CY2023Q2 us-gaap Inventory Net
InventoryNet
53126000
CY2023Q1 us-gaap Inventory Net
InventoryNet
51324000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2100000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2100000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11678000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12040000
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
248000000
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
53000000
CY2023Q2 us-gaap Land And Land Improvements
LandAndLandImprovements
2304000
CY2023Q1 us-gaap Land And Land Improvements
LandAndLandImprovements
2304000
CY2023Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
14162000
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
14158000
CY2023Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
25012000
CY2023Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
24960000
CY2023Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
13996000
CY2023Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
13972000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55474000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55394000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
41556000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
41106000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13918000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14288000
CY2023Q2 us-gaap Depreciation
Depreciation
400000
CY2022Q2 us-gaap Depreciation
Depreciation
400000
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
15900000
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
13875000
CY2023Q2 alot Guaranteed Minimum Royalty Payments
GuaranteedMinimumRoyaltyPayments
10000000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
858000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
794000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
312000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
275000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
581000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
555000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
263000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
258000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
199000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
151000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
93000
CY2023Q2 alot Lessee Operating Lease Liability Payment Due Year Five And Thereafter
LesseeOperatingLeaseLiabilityPaymentDueYearFiveAndThereafter
0
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
964000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
71000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
893000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0437
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
93000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
83000
CY2023Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
6000
CY2023Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
352000
CY2022Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
328000
CY2023Q2 alot Employee Stock Purchase Plan Expense
EmployeeStockPurchasePlanExpense
4000
CY2022Q2 alot Employee Stock Purchase Plan Expense
EmployeeStockPurchasePlanExpense
3000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
356000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
337000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
547199
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.16
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1700
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.5
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
175
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
18.35
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
4225
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.5
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
541099
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.21
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
541099
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
15.21
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y6M
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
541099
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
15.21
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y6M
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023 alot Reservation Of Shares Under Employee Stock Purchase Plan
ReservationOfSharesUnderEmployeeStockPurchasePlan
40000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.174
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.124
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
179000
CY2023Q2 alot Effective Income Tax Reconciliation Tax Expense Due To Uncertain Tax Positions
EffectiveIncomeTaxReconciliationTaxExpenseDueToUncertainTaxPositions
77000
CY2023Q2 alot Tax Expenses Benefits Resulting From Provisional Adjustments
TaxExpensesBenefitsResultingFromProvisionalAdjustments
29000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60000
CY2022Q2 alot Effective Income Tax Reconciliation Tax Expense Due To Uncertain Tax Positions
EffectiveIncomeTaxReconciliationTaxExpenseDueToUncertainTaxPositions
38000
CY2022Q2 alot Tax Expenses Benefits Resulting From Provisional Adjustments
TaxExpensesBenefitsResultingFromProvisionalAdjustments
30000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35419000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31010000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1461000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
764000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-434000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-279000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1027000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
485000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
179000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
848000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
425000

Files In Submission

Name View Source Status
0001193125-23-163282-index-headers.html Edgar Link pending
0001193125-23-163282-index.html Edgar Link pending
0001193125-23-163282.txt Edgar Link pending
0001193125-23-163282-xbrl.zip Edgar Link pending
alot-20230429.xsd Edgar Link pending
d292174d10q.htm Edgar Link pending
alot-20230429_def.xml Edgar Link unprocessable
alot-20230429_lab.xml Edgar Link unprocessable
alot-20230429_cal.xml Edgar Link unprocessable
alot-20230429_pre.xml Edgar Link unprocessable
d292174dex311.htm Edgar Link pending
d292174dex312.htm Edgar Link pending
d292174dex321.htm Edgar Link pending
d292174dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
d292174d10q_htm.xml Edgar Link completed
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable